CADL

Candel Therapeutics Inc

Price

$13.50

return (12m)

142.81%

p/e

-9.82

p/bv

6.89

DIVIDEND YIELD

0.00%

CADL price

Candel Therapeutics Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CADL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

31.77%

3 months

70.24%

1 year

142.81%

2 years

157.14%

5 years

70.24%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CADL

Valuation

P/E

-9.82

Sector 7.79

Industry 7.79

P/BV

6.89

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.22

Industry 2.22

EV/EBITDA

-19.26

Sector -156.98

Industry -156.98

EV/EBIT

-19.17

Sector -1,355,776,171.42

Industry -1,355,776,171.42

P/EBITDA

-10.46

Sector 2.51

Industry 2.51

P/EBIT

-10.37

Sector 0.34

Industry 0.34

P/Total Assets

4.18

Sector 1.00

Industry 1.00

P/Net Current Assets

7.12

Sector -3.84

Industry -3.84

P/Working Capital

4.54

Sector -5,077.26

Industry -5,077.26

EPS

-1.20

Sector 0.67

Industry 0.67

BVPS

1.70

Sector 10.17

Industry 10.17

Efficiency

Gross Margin

0.00%

Sector 32.61%

Industry 32.61%

EBITDA Margin

Sector -284.80%

Industry -284.80%

EBIT Margin

Sector -4.02%

Industry -4.02%

Operating Margin

0.00%

Sector 4.45%

Industry 4.45%

Net Profit Margins

0.00%

Sector 2.39%

Industry 2.39%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-70.20%

Sector 2.05%

Industry 2.05%

ROA

-42.54%

Sector -0.90%

Industry -0.90%

ROIC

-2,311.02%

Sector -118.95%

Industry -118.95%

Dividends

Dividend yield

0.00%

Sector 0.60%

Industry 0.60%

Payout

Sector 11.53%

Industry 11.53%

Debt

Current Ratio

16.09

Sector 1.44

Industry 1.44

Net Debt / EBITDA

4.14

Sector -39,522,158.34

Industry -39,522,158.34

Net Debt / EBIT

4.12

Sector -31.03

Industry -31.03

Net Debt / Equity

-1.22

Sector -0.72

Industry -0.72

Gross Debt / Equity

0.38

Sector 0.21

Industry 0.21

Equity/Assets

0.61

Sector 0.43

Industry 0.43

Liabilities/Assets

0.39

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

19.64%

Sector -

Industry -

Fundamentals CADL

DRAG THE FRAME TO SEE MORE DATA

CADL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Candel Therapeutics Inc

Candel Therapeutics Inc

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Candel Therapeutics Inc (United States) is listed on the Nasdaq and has a market capitalization of $869.50 million, with shareholders equity totaling $126.13 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Candel Therapeutics Inc reported $- in revenue, generating net income of $-88.54 million.

Key financial metrics include a P/E ratio of -9.82, a price-to-book (P/B) ratio of 6.89, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CADL.

Market cap

$869.50 million

Net worth

$126.13 million

$126,130,000.00

Assets

$208.15 million

$208,150,000.00

Total Shares Outstanding

74.00 million

74,000,000

Average Daily Trading Volume

$1.66 million

$1,655,150.74

Sector

Others

Industry

Others

CADL

CADL revenue and profits

Financial Results CADL

DRAG THE FRAME TO SEE MORE DATA

CADL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$388.61 33,84% (12M)

P/E

25.58

2.23%

ROE

13.33%

P/BV

3.41

SHEL - Shell PLC ADR

$92.77 34,82% (12M)

P/E

9.65

3.30%

ROE

14.29%

P/BV

1.38

STLA - Stellantis NV

$5.43 --44,42% (12M)

P/E

-0.61

0.00%

ROE

-35.93%

P/BV

0.22

COR - Cencora Inc.

$317.10 5,40% (12M)

P/E

22.86

0.76%

ROE

81.04%

P/BV

18.52

SSNLF - Samsung Electronics Co Ltd

$- -0,00% (12M)

P/E

13.54

4.85%

ROE

1.69%

P/BV

0.23

ALIZY - Allianz SE ADR

$51.08 --13,60% (12M)

P/E

14.12

2.66%

ROE

17.89%

P/BV

2.53

TTE - TotalEnergies SE ADR

$90.07 54,62% (12M)

P/E

7.06

4.61%

ROE

21.42%

P/BV

1.51

NSRGY - Nestle SA ADR

$99.21 9,18% (12M)

P/E

11.98

4.01%

ROE

58.05%

P/BV

6.96